U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Loreal Usa - 08/01/2017
  1. Warning Letters

CLOSEOUT LETTER

Loreal Usa


Recipient:
Loreal Usa

United States

Issuing Office:

United States


 

  

Black HHS-Blue FDA Logo

 

5001 Campus Drive
College Park, MD 20740

 
 

AUG 1, 2017

Brigitte Liberman,
President Active Cosmetics Division
L'Oreal USA
575 Fifth Avenue
New York, NY 10017

Dear Ms. Liberman:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter #440851 issued February 12, 2015. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,

/S/

Latasha A. Robinson
Branch Chief
Dietary Supplements & Labeling Assessment Branch
Office of Compliance
Center for Food Safety
    and Applied Nutrition 

Back to Top